Issues and challenges in developing long-acting veterinary antibiotic formulations

Advanced Drug Delivery Reviews

Volumn 56, Issue 10, 2004, Pages 1481-1496

  Sun, Yichun ^a   Scruggs, Daniel W ^b   Peng, Yingxu ^a   Johnson, James R ^a   Shukla, Atul J ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

Antibiotics; Drug delivery; Formulation development; Long acting formulations; Veterinary

Indexed keywords

ANTIBIOTICS; DISEASE CONTROL;

BACTERIAL INFECTIOUS DISEASE; DRUG DELIVERY;

VETERINARY MEDICINE;

AMIKACIN; AMINOGLYCOSIDE; AMINOPENICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BIO MYCIN 200; CARBENICILLIN; CEFTIOFUR; CEPHALOSPORIN; CHLORAMPHENICOL; CLOXACILLIN; DANOFLOXACIN; DOXIROBE; DOXYCYCLINE; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; GENTAMICIN BONE CEMENT; IVOMEC SR; KANAMYCIN; LA 200; MACROLIDE; MARBOFLOXACIN; NEOMYCIN; NOVOBIOCIN; ORBIFLOXACIN; OXYTETRACYCLINE; PARATECT FLEX; PEN BP 48; PENICILLIN G; PERIOCEUTIC; POLYMYXIN; PROCURE 200; PROTEIN SYNTHESIS INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RUMESIN ABC; SPANBOLET II; SULFONAMIDE; TETRACYCLINE; TILMICOSIN; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; CAT; CONCENTRATION RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPLANTATION; DRUG MEGADOSE; DRUG TOLERANCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SUSPENSION; VETERINARY MEDICINE;

EID: 2942572042     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2004.02.009     Document Type: Article

References (55)

1. Ahmed I., Kasraian K. Pharmaceutical challenges in veterinary product development. Adv. Drug Deliv. Rev. 54:2002;871-882
2. DeBoer D.J. Strategies for management of recurrent pyoderma in dogs. Vet. Clin. North Am., Small Anim. Pract. 20:1990;1509-1524
3. Chester D.K. Medical management of otitis externa. Vet. Clin. North Am., Small Anim. Pract. 18:1988;799-812
4. Rosser E.J. Jr. German shepherd dog pyoderma: a prospective study of 12 dogs. J. Am. Anim. Hosp. Assoc. 33:1997;355-363
5. Baxter G.M. Instrumentation and techniques for treating orthopedic infections in horses. Vet. Clin. North Am., Equine Pract. 12:1996;303-335
6. Dernell W.S. Treatment of severe orthopedic infections. Vet. Clin. North Am., Small Anim. Pract. 29:1999;1261-1274
7. Zetner K., Rothmueller G. Treatment of periodontal pockets with doxycycline in beagles. Vet. Ther. 3:2002;441-452
8. Cohen N.D., Woods A.M. Characteristics and risk factors for failure of horses with acute diarrhea to survive: 122 cases (1990-1996). J. Am. Vet. Med. Assoc. 214:1999;382-390
9. Wilson D.A., MacFadden K.E., Green E.M., Crabill M., Frankeny R.L., Thorne J.G. Case control and historical cohort study of diarrhea associated with administration of trimethoprim-potentiated sulphonamides to horses and ponies. J. Vet. Intern. Med. 10:1996;258-264
10. Booth T.M., Butson R.J., Clegg P.D., Schramme M.C., Smith R.K. Treatment of sepsis in the small tarsal joints of 11 horses with gentamicin-impregnated polymethylmethacrylate beads. Vet. Rec. 148:2001;376-380
11. Perkins N.R. Equine reproductive pharmacology. Vet. Clin. North Am., Equine Pract. 15:1999;687-704
12. FSIS National Residue Program Food Safety and Inspection Service, 2000, U.S. Department of Agriculture, Washington, DC.
13. http://www.informatics3.vetmed.vt.edu/.
14. Levison M.E. Pharmacodynamics of antibacterial drugs. Infect. Dis. Clin. North Am. 14:2000;281-291
15. Mouton J.W., Vinks A.A. Is continuous infusion of beta-lactam antibiotics worthwhile? - efficacy and pharmacokinetic considerations. J. Antimicrob. Chemother. 38:1996;5-15
16. MacGowan A.P., Bowker K.E. Continuous infusion of beta-lactam antibiotics. Clin. Pharmacokinet. 35:1998;391-402
17. Maddison J. Owner compliance with drug treatment regimens. J. Small Anim. Pract. 40:1999;348
18. Davison T.F., Freeman B.M. Physiologic aspects of growth promotion in poultry. Vet. Res. Commun. 7:1983;59-68
19. Walton J.R. Modes of action of growth promoting agents. Vet. Res. Commun. 7:1983;1-7
20. Droumev D. Review of antimicrobial growth promoting agents available. Vet. Res. Commun. 7:1983;85-99
21. Vermeulen B., De Backer P., Remon J.P. Drug administration to poultry. Adv. Drug Deliv. Rev. 54:2002;795-803
22. Hibbard B., Robb E.J., Chester S.T. Jr., Dame K.J., Moseley W.W., Bryson W.L. Dose determination and confirmation for ceftiofur crystalline-free acid administered in the posterior aspect of the ear for control and treatment of bovine respiratory disease. Vet. Ther. 3:2002;22-30
23. F.H. Buckwalter, Repository penicillin composition, in U.S. Patent. 1950: United States.
24. Buckwalter F.H., Dickison H.L. The effect of particle size on the absorption by intramuscular route of procaine penicillin G suspensions. J. Am. Pharm. Assoc. 47:1958;661-666
25. Aguiar A.J., Armstrong W.A., Desai S.J. Development of oxytetracycline long-acting injectable. J. Control. Release. 6:1987;375-385
26. Matschke C., Isele U., van Hoogevest P., Fahr A. Sustained-release injectables formed in situ and their potential use for veterinary products. J. Control Release. 85:2002;1-15
27. Cleland W.P. Jr. Opportunities and obstacles in veterinary dental drug delivery. Adv. Drug Deliv. Rev. 50:2001;261-275
28. Sun Y., Peng Y., Aksornkoae N., Johnson J.R., Boring J.G., Scruggs D., Cooper R.C., Laizure S.C., Shukla A.J. Controlled release of oxytetracycline in sheep. J. Control. Release. 85:2002;125-134
29. Veyries M.L., Couarraze G., Geiger S., Agnely F., Massias L., Kunzli B., Faurisson F., Rouveix B. Controlled release of vancomycin from poloxamer 407 gels. Int. J. Pharm. 192:1999;183-193
30. Mi F.L., Wong T.B., Shyu S.S. Sustained-release of oxytetracycline from chitosan microspheres prepared by interfacial acylation and spray hardening methods. J. Microencapsul. 14:1997;577-591
31. Ames T.R., Hyde F.W., Marabella C.P. Oxytetracycline-containing bovine serum albumin microspheres for treatment of calves with experimentally induced Pasteurella haemilytica pneumonia. J. Control. Release. 22:1992;219-222
32. Bodmeier R., Chen H., Davidson R.G., Hardee G.E. Microencapsulation of antimicrobial ceftiofur drugs. Pharm. Dev. Technol. 2:1997;323-334
33. Owusu-Ababio G., Rogers J.A. Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. J. Microencapsul. 13:1996;195-205
34. Kesler D.J., Bechtol D.T. Efficacy of sustained release needle-less ceftiofur sodium implants in treating calves with bovine respiratory disease. Zentralbl. Veterinarmed. Beith. 46:1999;25-35
35. Huang Y.Y., Chung T.W. Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J. Microencapsul. 18:2001;457-465
36. Bartlett J.G., Chang T.W., Moon N., Onderdonk A.B. Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia. Am. J. Vet. Res. 39:1978;1525-1530
37. Baverud V. Clostridium difficile infections in animals with special reference to the horse. A review. Vet. Q. 24:2002;203-219
38. Borriello S.P., Carman R.J. Association of iota-like toxin and Clostridium spiroforme with both spontaneous and antibiotic-associated diarrhea and colitis in rabbits. J. Clin. Microbiol. 17:1983;414-418
39. Regosz A. Fluorimetric determination of the active form of tetracycline, chloretetracycline and oxytetracycline in partially decomposed solutions. Pharmazie. 32:1977;681-683
40. http://www.usp.org/veterinary/monographs/penicillin_g.pdf.
41. Oberholtzer E.R., Brenner G.S. Cefoxitin sodium: solution and solid-state chemical stability studies. J. Pharm. Sci. 68:1979;863-866
42. Sunkara G., Navarre C.B., Kompella U.B. Influence of pH and temperature on kinetics of ceftiofur degradation in aqueous solutions. J. Pharm. Pharmacol. 51:1999;249-255
43. Brisaert M., Heylen M., Plaizier-Vercammen J. Investigation on the chemical stability of erythromycin in solutions using an optimization system. Pharm. World Sci. 18:1996;182-186
44. Chu C.C., Williams D.F. The effect of gamma irradiation on the enzymatic degradation of polyglycolic acid absorbable sutures. J. Biomed. Mater. Res. 17:1983;1029-1040
45. Akers M.J. Sterility testing. Robinson J.R. Parenteral Quality Control: Sterility, Pyrogen, Particulate, and Package Integrity Testing. 1994;43-45 Marcel Dekker, New York, NY
46. Atkins T.W., Peacock S.J., Yates D.J. Incorporation and release of vancomycin from poly(D, L-lactide-co-glycolide) microspheres. J. Microencapsul. 15:1998;31-44
47. Blanco-Prieto M., Lecaroz C., Renedo M., Kunkova J., Gamazo C. In vitro evaluation of gentamicin released from microparticles. Int. J. Pharm. 242:2002;203-206
48. Nouws J.F., Smulders A., Rappalini M. A comparative study on irritation and residue aspects of five oxytetracycline formulations administered intramuscularly to calves, pigs and sheep. Vet. Q. 12:1990;129-138
49. Van Donkersgoed J., Dixon S., Brand G., VanderKop M. A survey of injection site lesions in fed cattle in Canada. Can. Vet. J. 38:1997;767-772
50. Seguin B. Feline injection site sarcomas. Vet. Clin. North Am., Small Anim. Pract. 32:2002;983-995
51. Van Dresser W.R., Wilcke J.R. Drug residues in food animals. J. Am. Vet. Med. Assoc. 194:1989;1700-1710
52. Nouws J.F. Injection sites and withdrawal times. Ann. Rech. Vet. 21:1990;145S-150S
53. Nouws J.F. Irritation, bioavailability, and residue aspects of ten oxytetracycline formulations administered intramuscularly to pigs. Vet. Q. 6:1984;80-84
54. Burgess D.S. Pharmacodynamic principles of antimicrobial therapy in the prevention of resistance. Chest. 115:1999;19S-23S
55. Lathers C.M. Clinical pharmacology of antimicrobial use in humans and animals. J. Clin. Pharmacol. 42:2002;587-600